• Рузикулов О.Ш., Жураев И.Г., Хамидов О.А., Келдияров А.Х., Мансуров Дж.Ш., Садуллаев О.А.
  1 - Самарканский филиал Республиканского специализированного научно-практического меди-цинского центра травматологии и ортопедии, Республика Узбекистан, г. Самарканд; 2 - Самаркандский государственный медицинский университет, Республика Узбекистан, г. Самар-канд

Аннотация

Пациенты с переломами шейки бедренной кости, как правило, пожилые люди с несколькими сопутствующими заболеваниями. При поступлении в стационар у них часто отмечают острую боль, электролитные нарушения, анемию, коагулопатию и делирий. Повышенная смертность связана с длительным временем ожидания операции. Баланс между количеством клинических тестов и оптимизацией, которая может (т. е. меньше осложнений и лучшая выживаемость) или не может (т. е. больше осложнений и повышенная смертность из-за ненужной хирургической задержки) принести пользу пациенту. В этом кратком обзоре будут рассмотрены существующие клинические рекомендации и соответствующие избранные исследования для оценки степени предоперационной оптимизации, необходимой перед хирургическим вмешательством при переломе шейки бедренной кости.

Ключевые слова

перелом шейки бедренной кости, пациенты с сопут-ствующей патологией, оптимизация травматологи-ческой помощи.

Литература

1.    Воронов А.А., Фадеев Е.М., Спичко А.А. [и др.]. Возможности прогноза местных инфекционных осложнений при артропластике тазобедренного и коленного суставов // Медико-фармацевтический журнал «Пульс». 2021. - Т. 22. - № 12. - C. 106-111.

2.    Гайковая Л.Б., Ткаченко А.Н., Ермаков А.И.  [и др.]. Лабораторные маркеры прогноза инфекции области хирургического вмешательства при транспедикулярной фиксации позвоночника // Профилактическая и клиническая медицина. — 2018. — № 1 (66). — С. 50–56.

3.    Мансуров Д. Ш., и др. Обоснование медико-организационных мероприятий по улучшению профилактики и оценка вероятности развития инфекции в области хирургического вмешательства у пострадавших с переломами костей // Профилактическая и клиническая медицина. – 2019. – № 1(70). – С. 39-45.

4.    Ткаченко А.Н., Корнеенков А.А., Дорофеев Ю.Л. [и др.]. Оценка динамики качества жизни методами анализа выживаемости у пациентов, перенесших артропластику тазобедренного сустава // Гений ортопедии. 2021. Т. 27, № 5. С. 527-531.

5.    Щербак Н.П., Мансуров Д.Ш., Дорофеев Ю.Л. [и др.]. Особенности организации травматологической помощи в регионах Российской Федерации (научный обзор) // Физическая и реабилитационная медицина. - 2021. - Т. 3. - № 3. - С. 62-72.

6.    AAOS clinical practice guideline on management of hip fractures in the elderly. 2014. https://www.aaos.org/research/guidelines/HipFxGuideline.pdf

7.    Adair C, Swart E, Seymour R, Patt J, Karunakar MA. Clinical practice guide- lines decrease unnecessary echocardiograms before hip fracture surgery. JBJS Am 2017;99:676–80.

8.    Ahmed I, Khan MA, Nayak V, Mohsen A. An evidence-based warfarin manage- ment protocol reduces surgical delay in hip fracture patients. J Orthop Trau- matol 2014;15:21–7.

9.    Aicale R, Tarantino D, Maffuli N. Prevalence of hyponatremia in elderly patients with hip fractures: a two-year study. Med Prin Pract 2017;26:451–5.

10. Alagiakrisnan K, Mereu L. Aproach to managing hypoglycemia in elderly pa- tients with diabetes. Postgrad Med 2015;122:129–37.

11. Baker PN, Salar O, Ollivera BJ, Forward NW, Moppett LK, Moran CG. Evolution of the hip fracture population: time to consider the future? A retrospective observational analysis. BMJ Open 2014;4:e004405.

12. Carson JL, Stanworth SJ, Roubinian N, Fergusson DA, Trilulzi D, Doree C, et al. Transfusions thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2016;10 CD002042.

13. Cervellin G, Mitaritonno M, Padrazzoni M, Picanza A, Lippi G. Prevalence of hy- ponatremia in femur neck fractures. A one year survey in an urban emergency department. Advances Orthopedics 2014;2014:397059.

14. Chen Y, Yang X, Meng K, Zeng Z, Ma B, Liu X, et al. Stress-induced hypergly- caemia after hip fracture and the increased risk of acute myocardial infarction in nondiabetic patients. Diabetes Care 2013;36:3328–32.

15. Collinge CA, McWilliam-Ross K, Beltran MJ, Weaver T. Measures of clini- cal outcome before, during and after implementation of a comprehensive geriatric hip fracture program: is there a learning curve? J Orthop Trauma 2013;12:672–6.

16. Crowl AC, Young JS, Kahler DM, Claridge JA, Chrzanowski DS, Pomphrey M. Occult hypoperfusion is associated with increased morbidity in patients un- dergoing early femur fracture fixation. J Trauma 2000;48:260–7.

17. Crowther M, Cuker A. How can we reverse bleeding in patients on direct oral anticoagulants? Kardiol pol 2019;77:3–11.

18. Cumming K, Hoyle GE, Hutchison JD, Soiza RL. Prevalence, incidence and eti- ology of hyponatremia in elderly patients with fragility fractures. PLoS One 2014;9:e88272. doi:10.1371/journal.pone.0088272.

19. Dixon J, Ashton F, Baker P, Charlton K, Bates C, Eardley W. Assessment and early management of pain in hip fractures: the impact of Paracetamol. Geriatr Orthop Surg Rehabil 2018;9 2151459318806443.

20. Downey C, Kelly M, Quinlan JF. Changing trends in the mortality rate at 1-year post hip fracture–a systematic review. World J Orthop 2019;10:166–75.

21. El-Sharkawy AM, Sahota O, Maughan RJ, Lobo DN. The pathophysiology of fluid and electrolyte balance in the older adult surgical patient. Clinical Nutrition 2014;33:6–13.

22. Feldt KS, Ryden MB, Miles S. Treatment of pain in cognitively impaired com- pared with cognitively intact older patients with hip fracture. J Am Geriatr Soc 1998;46:1079–85.

23. Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, et al. 2014 ACC/AHA guidelines on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. a re- port of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2014;64:e77–137.

24. Global report on diabetes. 1. Diabetes mellitus – epidemiology. 2. Diabetes mellitus–prevention and control. 3. Diabetes–gestational. 4. Chronic disease. 5. Public health. Geneva: I. World Health Organization; 2016.

25. Graver A, Merwin S, Collins L, Kohn N, Goldman A. Comorbid profile rather than age determines hip fracture mortality in a nonagenarian population. HSSJ 2015;11:223–35.

26. Griffiths R, Alper J, Beckingsale A, Goldhill D, Heyburn G, et al., Association of Anaesthetists of Great Britain and Ireland Management of proximal femoral fractures 2011: association of anaesthetists of Great Britain and Ireland. Anaes- thesia 2012;67:85–98.

27. Gu WJ, Gu XP, Wu XD, Chen H, Kwong JSW, Zhou LY, et al. Restrictive versus liberal strategy for red blood cell transfusion. J Bone Joint Surg Am 2018;100:686–95.

28. Health in 2015. From MDGs, millennium development goals to SDGs, sustain- able development goals. Geneva: World Health Organization; 2015.

29. Hung WW, Egol KA, Zuckerman JD, Siu AL. Hip fracture management. Tailoring care for the older patient. JAMA 2012;307:2185–94.

30. Il Lo, CW Siu, Tse HF, Lau TW, Leung F, Wong M. Preoperative pulmonary as- sessment for patients with hip fracture. Osteoporos Int 2010;21:S579–86.

31. Jamali S, Dagher M, Bilani N, Mailhac A, Habbal M, Zeineldine S, et al. The effect of preoperative pneumonia on postsurgical mortality and morbidity: a nsqip analysis. World J Surg 2018;42:2763–72.

32. Janghorbani M, Van Dam RM, Willett WC, Hu FB. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 2007;166:495–505.

33. Joint British Diabetes Societies for Inpatient Care. Management of adults with diabetes undergoing surgery and elective procedures: improving standards. https://www.diabetes.org.uk/resources-s3/2017-09/Surgical%20guideline% 202015%20-%20summary%20FINAL%20amended%20Mar%202016.pdf

34. Juliebø V, Bjøro K, Krogseth M, Skovlund E, Ranhoff AH, Wyller TB. Risk fac- tors for preoperative and postoperative delirium in elderly patients with hip fracture. JAGS 2009;57:1353–61.

35. Juthani-Metha M. Asymptomatic bacteriuria and urinary tract infection in older adults. Clin Geriatr Med 2007;23:585–94.

36. Klinck J, McNeil L, Di Angelantonio E, Menon DK. Predictors and outcome im- pact of perioperative serum sodium changes in a high population. Br J Anaesth 2015;114:615–22.

37. Kosack CS, Page A-L, Klatser PR. A guide to aid the selection of diagnostic test. Bull World Health Organ 2017;95:639–45.

38. Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker HE, DeHert S, et al. 2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management. The joint task force on non-cardiac surgery: cardiovascular as- sessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 2014;35:2383–431.

39. Kumar D, Mbako AN, Riddick A, Patil S, Williams P. On admission haemoglobin in patients with hip fracture. Injury 2011;42:167–70.

40. Lewis JR, Hassan SKZ, Wenn RRT, Moran CG. Mortality and serum urea and electrolytes on admission for hip fracture patients. Injury 2006;37:698–704.

41. Lizaur-Utrilla A, Gonzalez-Navarro B, Vizcaya-Moreno MF, Munoz FAM, Gonzalez-Parreno S, Lopez-Prats FA. Reasons for delaying surgery following hip fractures and its impact on one year mortality. Int Orthop 2018.

42. Loggers SAI, Giannakopoulos GF, Vandewalle E, EArwteman M, Berger F, Zuidema WP. Preoperative chest radiographs in hip fracture patients: is there any additional value? Eur J Orthop Surg Traumatol 2017;27:953–9.

43. Madsen CM, Jantzen C, Lauritzen JB, Abrahamsen B, Jorgensen HL. Hypona- tremia and hypernatremia are associated with increased 30-day mortality in hip fracture patients. Osteoporos Int 2016;27:397–404.

44. Madsen CM, Jantzen C, Lauritzen JB, Abrahamsen B, Jorgensen HL. Tem- poral trends in the use of antithrombotics at admission. Acta Orthop 2016;87:368–73.

45. Morrison RS, Magaziner J, Gilbert M, Koval KJ, McLaughlin MA, Orosz G, et al. Relationship between pain and opioid analgesics on the development of delirium following hip fracture. J Gerontol A Biol Sci Med Sci 2003;58:76–81.

46. Mullins B, Akehurst H, Slatterry D, Chesser T. Should surgery be delayed in patients taking direct oral anticoagulants who suffer a hip fracture? A retro- spective, case-controlled observational study at a UK major trauma centre. BMJ Open 2018;8:e02625.

47. Munro J, Booth A, Nicholl J. Routine preoperative testing: a systematic review of the evidence. Health Technol Assess 1997;1:1–63.

48. NICE. The management of hip fractures in adults. 2014. https://www.nice.org. uk/guidance/cg124.

49. Norring-Agerskov D, Madsen CM, Abrahamsen B, Riis T, Pedersen OB, Jørgensen NR, et al. Hyperkalemia is associated with increased 30-day mor- tality in hip fracture patients. Calcif Tissue Int 2017;101:9–16.

50. Oh´ eireamhoin S, Beyer T, Ahmed M, Mulhall KJ. The role of preoperative cardiac investigation in emergency hip surgery. J Trauma 2011;71:1345–7.

51. Pailleret C, Hamou ZA, Rosencher N, Samama CM, Eyraud V, Chilot F, et al. Ret- rospective comparison between delayed and early hip fracture surgery in pa- tients taking clopidogrel: same total bleeding but different timing of blood transfusions. Int Orthop 2017;41:1839–44.

52. Parker MJ. Randomised trial of blood transfusion versus a restrictive transfu- sion policy after hip fracture surgery. Injury 2013;44:1916–18.

53. Patterson JT et all Does preoperative pneumonia affect complications of geriatric hip fracture surgery? Am J Orthop 2017;46:E177–85.

54. Pincus D, Wasserstein D, Ravi B, Huang A, Paterson JM, Jenkinson RJ, et al. Medical cost of delayed hip fracture surgery. JBJS Am 2018;100:1387–96.

55. Piper GL, Kaplan LJ. Fluid and electrolyte management for the surgical patient. Surg Clin N Am 2012;92:189–205.

56. Potter LJ, Doleman B, Moppett IK. A systematic review of pre-operative anaemia and blood transfusions in patients with fractured hips. Anaesthesia 2015;70:483–500.

57. Reguant F, Arnau A, Lorente JV, Maestro L, Bosch J. Ecacy of a multidisci- plinary approach on postoperative morbidity and mortality of elderly patients with hip fracture. J Clin Anesth 2019;53:11–19.

58. Roche JJ, Wenn RT, Sahota O, Moran CG. Effect of comorbidities and postoper- ative complications on mortality after hip fracture in elderly people: prospec- tive observational cohort study. BMJ 2005;331:1374.

59. Sobolev B, Guy P, Sheehan KJ, Kuramoto L, Sutherland JM, Levy AR, et al. Mortality effects of timing alternatives for hip fracture surgery. CMAJ 2018;7:E923–32 .

60. Shiga T, Wajima ZI, Ohe Y. Is operative delay associated with increased mor- tality of hip fracture patients? Systematic review, meta-analysis, and meta-re- gression. Can J Anesth 2008;55:135–9.

61. Vidán MT, Sánchez E, Gracia Y, Marañón E, Vaquero J, Serra JA. Causes and ef- fects of surgical delay in patients with hip fracture: A cohort study. Ann Intern Med 2011;155:226–33.

62. White SM, Sanghera P, Chakladar A. Leucocytosis increases length of inpa- tient stay but not age-adjusted 30-day mortality, after hip fracture. Age Ageing 2010;39:650–3.

63. Yassa R, Khalfaoui MY, Hujazi I, Sevennoaks H, Dunkow P. Management of anticoagulation in hip fractures: a pragmatic approach. EFFORT Open Rev 2017;2:394–402.

64. Yassa RRD et all Pre-operative urinary tract infection: is it a risk factor for early surgical site infection with hip fracture surgery? A retrospective analysis. JRSM Open 2017;8.

65. Zehir R, Zehir S, Kocabay G. Role of preoperative electrocardiography in pre- dicting cardiovascular complications in proximal femur surgery. Curr Res Car- diol 2015;2:171–4.